Stephen Van Davis, MD | |
200 Deer Run Rd, Danville, VA 24540-2866 | |
(434) 799-0090 | |
(434) 799-0098 |
Full Name | Stephen Van Davis |
---|---|
Gender | Male |
Speciality | Internal Medicine |
Experience | 43 Years |
Location | 200 Deer Run Rd, Danville, Virginia |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1124026588 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RC0000X | Internal Medicine - Cardiovascular Disease | 0101038033 (Virginia) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Citizens Memorial Hospital | Bolivar, MO | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Citizens Memorial Healthcare | 4183528169 | 106 |
Citizens Memorial Healthcare | 4183528169 | 106 |
News Archive
Gene drives are genetic elements - found naturally in the genomes of most of the world's organisms - that increase the chance of the gene they carry being passed on to all offspring, and thus, they can quickly spread through populations. Looking to these natural systems, researchers around the world, including some Wyss Institute scientists, are developing synthetic gene drives that could one day be leveraged by humans to purposefully alter the traits of wild populations of organisms to prevent disease transmission and eradicate invasive species.
News outlets report that a split federal appeals court on Tuesday debated whether individuals buying health insurance in the federal marketplace should be eligible for tax subsidies, presenting a potentially serious legal challenge to a central part of President Barack Obama's health care law.
A new study finds chemotherapy improves survival and reduces the risk of recurrence in women with stage I ovarian cancer (cancer that has not spread beyond the ovary). But it remains unclear which patients would most benefit from adjuvant chemotherapy and what the optimal treatment regimen would entail.
Nektar Therapeutics today announced positive preliminary initial results from a two-stage Phase 2 clinical study evaluating single-agent NKTR-102 in women with advanced/metastatic breast cancer patients who have received a prior taxane. The increased use of taxanes in breast cancer often renders tumors resistant to these drugs by the time the disease recurs, thereby underscoring the urgent need for new treatment options with novel mechanisms of action for metastatic disease.
​Astrocytomas are the most common malignant brain tumors. While most patients' tumors prove to be quite aggressive, outcomes overall can vary widely, with some patients surviving for many years.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Stephen Van Davis, MD 200 Deer Run Rd, Danville, VA 24540-2866 Ph: (434) 799-0090 | Stephen Van Davis, MD 200 Deer Run Rd, Danville, VA 24540-2866 Ph: (434) 799-0090 |
News Archive
Gene drives are genetic elements - found naturally in the genomes of most of the world's organisms - that increase the chance of the gene they carry being passed on to all offspring, and thus, they can quickly spread through populations. Looking to these natural systems, researchers around the world, including some Wyss Institute scientists, are developing synthetic gene drives that could one day be leveraged by humans to purposefully alter the traits of wild populations of organisms to prevent disease transmission and eradicate invasive species.
News outlets report that a split federal appeals court on Tuesday debated whether individuals buying health insurance in the federal marketplace should be eligible for tax subsidies, presenting a potentially serious legal challenge to a central part of President Barack Obama's health care law.
A new study finds chemotherapy improves survival and reduces the risk of recurrence in women with stage I ovarian cancer (cancer that has not spread beyond the ovary). But it remains unclear which patients would most benefit from adjuvant chemotherapy and what the optimal treatment regimen would entail.
Nektar Therapeutics today announced positive preliminary initial results from a two-stage Phase 2 clinical study evaluating single-agent NKTR-102 in women with advanced/metastatic breast cancer patients who have received a prior taxane. The increased use of taxanes in breast cancer often renders tumors resistant to these drugs by the time the disease recurs, thereby underscoring the urgent need for new treatment options with novel mechanisms of action for metastatic disease.
​Astrocytomas are the most common malignant brain tumors. While most patients' tumors prove to be quite aggressive, outcomes overall can vary widely, with some patients surviving for many years.
› Verified 3 days ago
Dr. Buddy Buford Stokes Ii, D.O. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1955 Memorial Dr, Danville, VA 24541 Phone: 434-799-2055 Fax: 434-799-2044 | |
Dr. Daniel Demetrios Collector, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 109 Bridge St Ste 201, Danville, VA 24541 Phone: 434-799-4488 Fax: 434-773-6977 | |
Dr. Timothy Wayne Brotherton, M,D, Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 125 Executive Dr, Ste J, Danville, VA 24541 Phone: 434-793-0044 Fax: 434-792-8864 | |
Syed Aftab Ahmed, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 125 Executive Dr, Suite K, Danville, VA 24541 Phone: 434-792-7471 Fax: 434-792-1087 | |
Dr. Stecker Tam Pierson, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 125 Executive Dr Ste H, Danville, VA 24541 Phone: 434-791-1345 Fax: 434-773-6811 | |
Subash Ala, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 142 S Main St, Danville, VA 24541 Phone: 434-799-2225 | |
Sheranda C Gunn-nolan, D.O. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 142 S Main St, Danville, VA 24541 Phone: 434-799-3859 Fax: 434-773-6803 |